Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.40
Bid: 144.60
Ask: 145.00
Change: -0.40 (-0.28%)
Spread: 0.40 (0.277%)
Open: 138.00
High: 145.00
Low: 138.00
Prev. Close: 144.80
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

15 Mar 2022 07:53

RNS Number : 8059E
Elementis PLC
15 March 2022
 

 

 

 

 

15 March 2022Elementis plc

Directorate Changes

Elementis plc (ELM.L) (the "Company"), global specialty chemicals company, today announces the following changes to the Board of Directors:

 

Anne Hyland, Chair of the Audit Committee will retire from the Board at the Company's Annual General Meeting (AGM) on 26 April 2022, consequently Anne will not be seeking re-election at the AGM.

 

Christine Soden will assume the role of Chair of the Audit Committee, effective from the AGM and will remain as Designated Non-Executive Director for workforce engagement. Christine is an existing member of the Audit Committee and has been deemed by the Board to have significant, recent and relevant financial experience with competence in accounting.

 

Dr. Geertrui (Trudy) Schoolenberg has been appointed as a Non-Executive Director with immediate effect and will join the Audit, Nomination and Remuneration Committees. Trudy will assume the role of Senior Independent Director at the conclusion of the Annual General Meeting on 26 April 2022.

 

Trudy has over 30 years' experience of working in the chemicals, engineering and high performance product sectors, including over 20 years with Royal Dutch Shell where she led business strategy and growth plans for Shell Chemicals. As well as strategy and growth experience, Dr Schoolenberg has strong operational knowledge, gained both during her time at Shell and thereafter at Akzo Nobel from 2013-2017 where she was Global Director SRD of Akzo Nobel Decorative Paints.

 

Dr Schoolenberg is a non-executive director of Accsys Technologies plc (AIM and Euronext listed), Supervisory board member of Avantium N.V.(Euronext Amsterdam SmallCap Index) and SPIE SA (Euronext Paris). Trudy previously served as non-executive director and senior independent director at Spirax-Sarco Engineering plc (2012-2021), non-executive director and senior independent director of Low and Bonar plc (2013-2020) and non-executive director of not for profit, The Netherlands Petroleum Stockpiling Agency (COVA) (2011-2021).

Dr Schoolenberg has a Ph.D in Technical Physics from the Delft University of Technology (The Netherlands) and holds a master's degree in Industrial Engineering.

 

Steve Good will remain as Chair of the Remuneration Committee and as a member of the Nomination Committee following the Annual General Meeting.

 

At the conclusion of the AGM, the membership of the Board Committees will be:

 

· Audit Committee: Christine Soden (Chair), Dorothee Deuring and Trudy Schoolenberg

· Remuneration Committee: Steve Good (Chair), Dorothee Deuring, John O'Higgins and Trudy Schoolenberg

· Nomination Committee: John O'Higgins (Chair), Dorothee Deuring, Steve Good, Trudy Schoolenberg and Christine Soden

 

 

 

John O'Higgins, Chair of Elementis, said:

 

 "I am delighted that Trudy is joining the Elementis Board. Trudy's skills and background demonstrate in-depth knowledge of the chemicals sector, global markets, technical innovation and the ESG agenda. She has a strong international perspective and is an experienced Board member with substantial UK Plc experience.

 

We will greatly miss Anne's contribution and commitment to Elementis. Anne leaves with the Board's best wishes and we wish her well for the future. "The Company confirms that there are no other matters requiring disclosure pursuant to LR 9.6.13R (1) to (6) in respect of Trudy Schoolenberg's appointment.

 

 

Laura HigginsGroup Company Secretary020 7067 2999

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVVBRUAUOARR
Date   Source Headline
3rd May 202411:46 amRNSHolding(s) in Company
1st May 202410:06 amRNSTotal Voting Rights
30th Apr 202411:36 amRNSResult of AGM
30th Apr 20247:00 amRNSFirst quarter trading update
29th Apr 202412:13 pmRNSResponse to open letter from Gatemore
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.